发明名称 Release-control composition
摘要 <p>The present invention relates to a controlled release capsule preparation for oral administration, which contains (i) a granule containing a physiologically active substance which is a compound represented by the formula: wherein n is an integer of 1 to 3, and Ar is an aromatic ring optionally having substituent(s), or a salt thereof, and a hydrophilic polymer, and coated with an enteric coating agent and the like, and (ii) a fluidizer. According to the present invention, a controlled release composition for oral administration of an imidazole derivative, which has steroid C 17,20 -lyase inhibiting activity and which has remarkably improved sustainability of the blood concentration, is provided.</p>
申请公布号 EP1854463(A1) 申请公布日期 2007.11.14
申请号 EP20060715493 申请日期 2006.03.03
申请人 TAKEDA PHARMACEUTICAL COMPANY LIMITED 发明人 ISHIDA, HAJIME;NOMURA, YUKIHIRO
分类号 A61K31/4164;A61K9/52;A61K47/04;A61K47/32;A61K47/38;A61P35/00 主分类号 A61K31/4164
代理机构 代理人
主权项
地址